These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38455795)

  • 1. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
    Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
    Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
    Sinha S; Kar C; Das S; Dutta A; De A
    Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
    Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
    J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Cutaneous Adverse Drug Reactions Reported at the Regional ADR Monitoring Center.
    Modi A; Desai M; Shah S; Shah B
    Indian J Dermatol; 2019; 64(3):250. PubMed ID: 31148872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
    Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
    Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
    Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
    Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
    Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
    Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological Pattern of Cutaneous Adverse Drug Reactions due to Antiepileptic Drugs in Eastern India.
    Singh PK; Kumar MK; Kumar D; Kumar P
    J Clin Diagn Res; 2015 Jan; 9(1):WC01-3. PubMed ID: 25738068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.
    Mahadevappa M; Meher C; Pushpa NB; Kulkarni P; Poornima KS; Desai N
    Indian J Med Res; 2022 Jul; 156(1):111-121. PubMed ID: 36510903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.
    Jha N; Alexander E; Kanish B; Badyal DK
    Indian Dermatol Online J; 2018; 9(5):299-303. PubMed ID: 30258795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance Study of Anticancer Drugs in a Tertiary Care Teaching Hospital in North India: A Retrospective Study.
    Kumar R; Jindal A; Garg P; Kaur A; Kumar S; Tilak Raj R; Singh S
    Cureus; 2023 Sep; 15(9):e44984. PubMed ID: 37822427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
    Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
    Sushma M; Noel MV; Ritika MC; James J; Guido S
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
    Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
    Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Clinical Spectrum of Cutaneous Adverse Drug Reactions in Patients Presenting at a Tertiary Care Hospital in Pakistan.
    Hina A; Masood S; Jamil S; Tabassum S; Jalil P; Ghulam U
    Cureus; 2021 Apr; 13(4):e14568. PubMed ID: 34026384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous adverse drug reactions in a tertiary care teaching hospital: A North Indian perspective.
    Nandha R; Gupta A; Hashmi A
    Int J Appl Basic Med Res; 2011 Jan; 1(1):50-3. PubMed ID: 23776774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
    Sharma R; Dogra D; Dogra N
    Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.